|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-4-9
|
|
pubmed:abstractText |
We evaluate the therapeutic effect of intravesical interleukin-2 (IL-2) on T1 papillary bladder carcinoma after incomplete transurethral resection.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
159
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1183-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9507828-Administration, Intravesical,
pubmed-meshheading:9507828-Adult,
pubmed-meshheading:9507828-Aged,
pubmed-meshheading:9507828-Carcinoma, Papillary,
pubmed-meshheading:9507828-Female,
pubmed-meshheading:9507828-Follow-Up Studies,
pubmed-meshheading:9507828-Humans,
pubmed-meshheading:9507828-Interleukin-2,
pubmed-meshheading:9507828-Male,
pubmed-meshheading:9507828-Middle Aged,
pubmed-meshheading:9507828-Neoplasm Recurrence, Local,
pubmed-meshheading:9507828-Neoplasm Staging,
pubmed-meshheading:9507828-Urinary Bladder Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Intravesical interleukin-2 in T1 papillary bladder carcinoma: regression of marker lesion in 8 of 10 patients.
|
|
pubmed:affiliation |
Department of Functional Morphology, Utrecht University, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
